Dark Forest Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-146,001	Closed	-$432K	–	938
2024 Q2	$432K	Buy	146,001 +45,721	+46%	+$173K	0.08%	306
2024 Q1	$454K	Buy	100,280 +89,790	+856%	+$458K	0.08%	313
2023 Q4	$59.9K	Sell	10,490 -268,128	-96%	-$1.24M	0.01%	419
2023 Q3	$1.28M	Buy	278,618 +185,606	+200%	+$1.13M	0.11%	312
2023 Q2	$601K	Buy	93,012 +77,822	+512%	+$531K	0.06%	559
2023 Q1	$115K	Buy	15,190 +13,677	+904%	+$124K	0.03%	612
2022 Q4	$15.3K	Buy	1,513 +1,229	+433%	+$14.2K	﹤0.01%	638
2022 Q3	$3K	Sell	284 -1,985	-87%	-$21.8K	﹤0.01%	959
2022 Q2	$24K	Sell	2,269 -8,809	-80%	-$74.6K	0.01%	461
2022 Q1	$108K	Buy	11,078 +7,894	+248%	+$74.7K	0.03%	482
2021 Q4	$46K	Buy	+3,184	New	+$48.3K	0.02%	467
2021 Q3	–	Sell	-157	Closed	-$3K	–	1222
2021 Q2	$3K	Buy	+157	New	+$4.33K	﹤0.01%	729